tributyrin: Clinical Trials

4 trials of tributyrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Recruiting 2, Completed 1, Terminated 1
Phase 22Recruiting 2

Follow tributyrin: new trials by email Literature Review of tributyrin trials Research Report on tributyrin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Tributyrin, Placebo - Parkinson Disease, Multiple System Atrophy
Phase 1 / Phase 2RecruitingPrabesh Kanel152026-10-012026-11-05
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Tributyrin, Placebo - Parkinson Disease, Parkinson Disease Dementia
Phase 1 / Phase 2RecruitingPrabesh Kanel452025-11-072026-11-13
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
tributyrin - Parkinson Disease
Phase 1TerminatedNicolaas Bohnen, MD, PhD182022-07-012025-01-23
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
chemotherapy, tributyrin - Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of Maryland, Baltimore241995-08-012019-11-04

Conditions studied

Parkinson Disease (3)  ·  Multiple System Atrophy (1)  ·  Prostatic Neoplasms (1)  ·  Supranuclear Palsy, Progressive (1)

Sponsors

Prabesh Kanel (2)  ·  Nicolaas Bohnen, MD, PhD (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (4)

Top investigators

Prabesh Kanel, PhD (2)  ·  David A. Van Echo, MD (1)  ·  Nicolaas I Bohnen, MD, PhD (1)